Earnings History Data for Bristol-Myers Squibb Company (BMY) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products. It offers products which includes hematology, oncology, cardiovascular and immunology. Bristol-Myers Squibb Company, formerly known as Bristol-Myers Company, is based in New York.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
31-10-2024	PM		BMY	Bristol-Myers Squibb Company	106,440	1.80	1.49	2.00	Bristol-Myers Squibb Company Non-GAAP EPS of $1.80 beats by $0.30, revenue of $11.89B beats by $640M [10/31/2024 7:00 AM]	55.84	3.19 (6.05%)	53.50	0.84 (1.60%)	39.35 - 56.20	14,245,095	7,420,000	170,036
Bristol Myers Squibb Q3 2024 Earnings Preview: Profit decline anticipated [10/30/2024 3:07 PM] Bristol-Myers Squibb Company Non-GAAP EPS of $1.80 beats by $0.30, revenue of $11.89B beats by $640M [10/31/2024 7:00 AM] Bristol-Myers raises outlook ahead of consensus after Q3 beat [10/31/2024 7:45 AM] Bristol-Myers Squibb in charts: Q3 revenue from Eliquis, Opdivo, Yervoy rises, Sprycel falls [10/31/2024 8:43 AM] Bristol Myers Squibb Reports Third Quarter Financial Results for 2024 [2024-10-31 06:59AM]
26-07-2024	PM		BMY	Bristol-Myers Squibb Company	90,530	2.07	1.64	1.75	Bristol-Myers Squibb Company Non-GAAP EPS of $2.07 beats by $0.44, revenue of $12.2B beats by $680M [7/26/2024 7:00 AM]	50.42	5.15 (11.39%)	48.13	2.86 (6.32%)	39.35 - 63.89	28,773,161	16,940,000	1,523,441
Earnings summary: Bristol-Myers Squibb Q2 results top estimates, raises adj. EPS outlook [7/26/2024 7:16 AM] Bristol-Myers Squibb in charts: Q2 revenue from Eliquis, Opdivo climb, while Sprycel falls [7/26/2024 7:34 AM] Bristol-Myers Squibb Company Non-GAAP EPS of $2.07 beats by $0.44, revenue of $12.2B beats by $680M [7/26/2024 7:00 AM] Biggest stock movers today:WW, MMM, DXCM, COUR, and more [7/26/2024 10:26 AM] Bristol-Myers hits three-month high on Q2 beat and trial win (update) [7/26/2024 1:00 PM]
25-04-2024	PM		BMY	Bristol-Myers Squibb Company	99,070	1.90	1.53	2.05	Bristol-Myers Squibb Company Non-GAAP EPS of -$4.40 beats by $0.02, revenue of $11.78B beats by $330M [4/25/2024 7:01 AM]	44.74	-4.12 (-8.43%)	47.50	-1.36 (-2.78%)	44.37 - 70.93	40,661,824	11,420,000	267,928
Bristol-Myers to cut 2,200 jobs as part of $1.5B cost savings plan [4/25/2024 10:08 AM] Bristol-Myers posts Q1 beat despite growth headwinds [4/25/2024 7:56 AM] Bristol-Myers in charts: Revenue from Eliquis rises, while Opdivo drops in Q1 [4/25/2024 7:44 AM] Bristol-Myers Squibb Company Non-GAAP EPS of -$4.40 beats by $0.02, revenue of $11.78B beats by $330M [4/25/2024 7:01 AM] Bristol-Myers Earnings Preview: Major near-term headwinds invite worries about Q1 results [4/24/2024 9:38 AM]
02-02-2024	PM		BMY	Bristol-Myers Squibb Company	99,440	1.70	1.52	1.82	Bristol-Myers Squibb beats top-line and bottom-line estimates; initiates FY24 outlook [2/2/2024 7:01 AM]	48.73	0.06 (0.12%)	49.25	0.58 (1.19%)	48.08 - 75.18	20,776,985	15,280,000	1,767,605
Earnings preview: Bristol Myers seen reporting lower Q4 earnings Friday [2/1/2024 4:30 PM] U.S. govt. opens bids in Medicare drug price negotiations [2/1/2024 10:13 AM] Bristol-Myers Squibb beats top-line and bottom-line estimates; initiates FY24 outlook [2/2/2024 7:01 AM] Bristol-Myers Squibb beats in Q4 as Eliquis and Opdivo outperform [2/2/2024 7:49 AM]
26-10-2023	PM		BMY	Bristol-Myers Squibb Company	117,240	2.00	1.76	1.99	Bristol-Myers Squibb Company Non-GAAP EPS of $2.00 beats by $0.23, revenue of $10.97B in-line [10/26/2023 7:03 AM]	53.01	-3.60 (-6.37%)	53.82	-2.79 (-4.93%)	52.98 - 81.43	20,835,611	11,700,000	1,099,419
Bristol Myers expected to report lower Q3 earnings amid generic competition [10/25/2023 11:30 AM] Bristol-Myers Squibb Company Non-GAAP EPS of $2.00 beats by $0.23, revenue of $10.97B in-line [10/26/2023 7:03 AM] Bristol-Myers posts another sales decline in Q3 amid Revlimid overhang [10/26/2023 7:45 AM]
27-07-2023	PM		BMY	Bristol-Myers Squibb Company	135,990	1.75	2.00	1.93	Bristol-Myers Squibb Company Non-GAAP EPS of $1.75 misses by $0.24, revenue of $11.2B misses by $610M [7/27/2023 7:00 AM]	60.76	-2.65 (-4.18%)	60.81	-2.60 (-4.10%)	60.38 - 81.43	18,678,296	8,490,000	968,672
Bristol-Myers Squibb set to continue streak of EPS beats with Q2 results [7/26/2023 1:20 PM] Bristol-Myers Squibb Company Non-GAAP EPS of $1.75 misses by $0.24, revenue of $11.2B misses by $610M [7/27/2023 7:00 AM] Bristol-Myers sets below-consensus guidance amid generic competition [7/27/2023 8:17 AM] Bristol slumps to 52-week low on earnings, guidance disappointments [7/27/2023 3:37 PM]
27-04-2023	PM	7:00 AM ET (Apr 27)	BMY	Bristol-Myers Squibb Company	147,740	2.05	1.98	1.96	Bristol-Myers Squibb Company Non-GAAP EPS of $2.05 beats by $0.05, revenue of $11.3B misses by $290M [4/27/2023 7:33 AM]	67.58	-0.44 (-0.64%)	67.94	-0.08 (-0.12%)	65.28 - 81.43	8,604,214	6,400,000	40,423
Bristol-Myers Squibb CEO Giovanni Caforio to retire in November [4/26/2023 5:32 PM] Democratic senators introduce bill to enhance CMS drug price negotiations [4/26/2023 1:21 PM] Bristol-Myers Squibb Company Non-GAAP EPS of $2.05 beats by $0.05, revenue of $11.3B misses by $290M [4/27/2023 7:33 AM] Bristol Myers stock dips as Q1 revenue falls amid generic impact on Revlimid [4/27/2023 8:17 AM] Hot Stocks: TDOC, LLY, ROKU and CMCSA rises on earnings; DBX falls on layoffs; LUV, CAT and BMY slides [4/27/2023 1:01 PM]
02-02-2023	PM	7:00 AM ET (Feb 2)	BMY	Bristol-Myers Squibb Company	153,150	1.82	1.71	1.83	Bristol-Myers Squibb Company Non-GAAP EPS of $1.82 beats by $0.09, revenue of $11.4B beats by $200M [2/2/2023 7:00 AM]	72.81	1.58 (2.22%)	71.75	0.52 (0.73%)	62.90 - 81.43	9,966,219	8,220,000	53,544
Will Bristol Myers Q4 revenues see boost from potential blockbuster Sotyktu? [2/1/2023 12:10 PM] Bristol-Myers Squibb Company Non-GAAP EPS of $1.82 beats by $0.09, revenue of $11.4B beats by $200M [2/2/2023 7:00 AM] Bristol Myers Q4 revenue falls as Revlimid continues to take hit from generics; FY23 outlook in higher range [2/2/2023 8:08 AM]
25-10-2022	PM	7:00 AM ET (Oct 26)	BMY	Bristol-Myers Squibb Company	155,850	1.99	1.83	2.00	Bristol Myers Squibb Non-GAAP EPS of $1.99 beats by $0.16, revenue of $11.22B beats by $40M, re-affirms FY22 outlook [10/26/2022 3:17 AM]	74.41	1.64 (2.25%)	72.50	-0.27 (-0.37%)	53.22 - 80.59	8,197,383	8,000,000	60,499
Bristol Myers Squibb Non-GAAP EPS of $1.99 beats by $0.16, revenue of $11.22B beats by $40M, re-affirms FY22 outlook [10/26/2022 3:17 AM] Bristol Myers Squibb Q3 2022 Earnings Preview [10/25/2022 10:07 AM] Bristol Myers Q3 sales fall amid generic competition to Revlimid, forex woes [10/26/2022 5:04 AM] Bristol Myers MS drug Zeposia recipients mounted serologic response to COVID vaccines in trial [10/26/2022 6:18 AM]
27-07-2022	PM	7:00 AM ET (Jul 27)	BMY	Bristol-Myers Squibb Company	155,320	1.93	1.79	1.93	Bristol Myers Squibb Non-GAAP EPS of $1.93 beats by $0.12, revenue of $11.9B beats by $400M, cuts FY22 outlook [7/27/2022 7:02 AM]	74.72	1.09 (1.48%)	72.20	-1.43 (-1.94%)	53.22 - 80.59	7,464,561	9,070,000	84,450
Will Bristol Myers Squibb positive earnings momentum continue in Q2? [7/26/2022 9:50 AM] Bristol Myers Squibb Non-GAAP EPS of $1.93 beats by $0.12, revenue of $11.9B beats by $400M, cuts FY22 outlook [7/27/2022 7:02 AM] Bristol Myers slips as forex impact triggers 2022 guidance cut [7/27/2022 8:00 AM] Drugmakers Hope New Heart Drugs Boost Sales, Revive Market [Jul-26-22 04:42PM] Drug, Biotech Stocks' Q2 Earnings on Jul 27: BMY, GSK & More [Jul-26-22 11:04AM] Revlimid sales drive higher-than-expected Bristol Myers results [Jul-27-22 07:00AM] Revlimid sales drive higher-than-expected Bristol Myers results [Jul-27-22 06:59AM]
29-04-2022	PM	7:00 AM ET (Apr 29)	BMY	Bristol-Myers Squibb Company	161,110	1.96	1.92	1.74	Bristol Myers Squibb Non-GAAP EPS of $1.96 beats by $0.07, revenue of $11.6B beats by $260M [4/29/2022 7:01 AM]	75.29	-1.91 (-2.47%)	73.50	-3.70 (-4.79%)	53.22 - 78.17	22,866,356	13,990,000	163,078
Will Bristol Myers Squibb positive earnings momentum continue in Q1? [4/28/2022 11:54 AM] Bristol Myers Squibb Non-GAAP EPS of $1.96 beats by $0.07, revenue of $11.6B beats by $260M [4/29/2022 7:01 AM] Bristol Myers stock dips despite Q1 beat, as FY22 EPS outlook trimmed, Revlimid to see decline [4/29/2022 8:06 AM] Bristol Myers, LianBio win FDA approval for Camzyos to treat heart disorder [4/29/2022 6:24 AM] Dow Jones Futures: Market Rebounds, But For How Long? Apple, Amazon Hit Techs [Apr-28-22 08:56PM] U.S. Food and Drug Administration Approves Camzyos (mavacamten) for the Treatment of Adults With Symptomatic New York Heart Association Class II-III Obstructive Hypertrophic Cardiomyopathy (HCM) to Improve Functional Capacity and Symptoms [Apr-28-22 08:01PM] Drug/Biotech Stocks Q1 Earnings Due on Apr 29: BMY, ABBV, AZN [Apr-28-22 10:53AM] Why Bristol-Myers (BMY) Might Surprise This Earnings Season [Apr-28-22 08:40AM] UPDATE 1-FDA approves Bristol Myers' heart disease drug [Apr-28-22 09:06PM] Dow Jones Futures: Apple, Amazon Hit Techs After Market Rebound; Elon Musk Sells Tesla Stock [Apr-28-22 10:10PM] UPDATE 2-FDA approves Bristol Myers' oral heart disease drug [Apr-28-22 09:06PM] Dow Jones Futures Fall On Apple, Amazon After Market Rebound; Tesla Rises On Elon Musk Move [Apr-29-22 06:43AM] Bristol Myers Squibb Reports First Quarter Financial Results for 2022 [Apr-29-22 06:59AM] Bristol Myers 1st-quarter sales up on Eliquis, Opdivo [Apr-29-22 07:04AM] Bristol Myer Squibb's stock falls after cutting adjusted EPS for 2022 [Apr-29-22 07:32AM] Bristol Myers Squibb Dives As Generics, Revlimid Rivals Slam 2022 Outlook [Apr-29-22 08:49AM] R&D Facility Building in the UK Exemplifies Sustainability Innovation [Apr-29-22 09:04AM] Bristol Myers Takes Machete To 2022 Outlook As Generics Slam Revlimid, Abraxane [Apr-29-22 09:33AM] Dow Jones Falls, Techs Slide After Market Rebound; Tesla Rises On Elon Musk Move [Apr-29-22 09:49AM] Dow Jones Well Off Lows As Apple Rises; Tesla Jumps On Elon Musk Move [Apr-29-22 10:02AM] Bristol Myers Squibb (BMY) Q1 Earnings and Revenues Surpass Estimates [Apr-29-22 08:15AM] Dow Jones Off Lows As Apple Rises; Tesla Jumps On Elon Musk Move [Apr-29-22 10:15AM] Dow Jones Falls, Nasdaq Skids On Amazon, AbbVie; Tesla Rises On Elon Musk Move [Apr-29-22 10:43AM] Amazon, Robinhood Slump in Premarket; Apple, Exxon, Bristol Myers-Squibb Fall [Apr-29-22 04:48AM] Bristol Myers Q1 Earnings Surpass Street Expectations, Lowers FY22 Guidance [Apr-29-22 08:09AM] FDA OKs heart drug at center of $13 billion deal for Peninsula company [Apr-29-22 11:12AM] PCE +6.6%, Another 40-Year High; XOM, CL, BMY Report [Apr-29-22 10:40AM] Core PCE Inflation at a 40-Year High in March [Apr-29-22 11:19AM] Bristol Myers Squibb (BMY) Q1 2022 Earnings Call Transcript [Apr-29-22 02:00PM] Bristol-Myers (BMY) Q1 Earnings Beat Estimates, Guidance Down [Apr-29-22 12:29PM]
04-02-2022	PM	7:00 AM ET (Feb 4)	BMY	Bristol-Myers Squibb Company	143,830	1.83	1.83	1.46	Bristol Myers Squibb Non-GAAP EPS of $1.83 beats by $0.03, revenue of $12B in-line [2/4/2022 7:00 AM]	65.00	0.93 (1.45%)	63.10	-0.97 (-1.51%)	53.22 - 69.75	10,652,060	13,910,000	190,279
Can Bristol Myers (BMY) maintain positive earnings momentum in Q4? [2/3/2022 7:13 AM] Bristol Myers Squibb Non-GAAP EPS of $1.83 beats by $0.03, revenue of $12B in-line [2/4/2022 7:00 AM] Bristol-Myers sets 2022 guidance ahead of consensus after earnings beat [2/4/2022 7:32 AM] Garnet Equity Capital Holdings, Inc. Buys Flex, Hertz Global Holdings Inc, Universal Display ... [Feb-03-22 09:38PM] Bristol Myers posts slightly better-than-expected 4th-qtr results [Feb-04-22 07:00AM] Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021 [Feb-04-22 06:59AM] Bristol-Myers Stock Gains As Opdivo, Eliquis Sales Drive Q4 Earnings Beat [Feb-04-22 02:18AM] Bristol's stock gains after beating earnings estimates for the fourth quarter [Feb-04-22 07:29AM] Dow Jones Futures Fall Ahead Of Jobs Report; Amazon Soars, But Ford Dives On Earnings [Feb-04-22 08:08AM] Dow Jones Futures Slide On Jobs Report; Amazon Soars, But Ford Dives On Earnings [Feb-04-22 08:35AM] Dow Jones Futures Slide As Yields Surge On Jobs Report; Amazon Soars, But Ford Dives On Earnings [Feb-04-22 08:37AM] ADDING and REPLACING Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021 [Feb-04-22 08:49AM] Bristol Myers Ekes Out Earnings Beat As Cancer Drugs Spur Growth [Feb-04-22 09:14AM] Dow Jones Falls As Yields Surge On Jobs Report; Amazon Soars, But Ford Dives On Earnings [Feb-04-22 09:32AM] Oak Asset Management, LLC Buys Science Applications International Corp, Merck Inc, ... [Feb-04-22 09:38AM] Bristol Myers Squibb (BMY) Q4 Earnings Meet Estimates [Feb-04-22 08:25AM] Amazon, Snap, Pinterest Rise Premarket; Ford, Clorox Fall [Feb-04-22 02:58AM] Stock Market Reverses Higher After Hot Jobs Report, Amazon Earnings [Feb-04-22 10:14AM] Bristol Myers Expects $10.5 Billion Shortfall This Year As Generics Loom [Feb-04-22 11:05AM] Stocks Trade Mixed On Strong Jobs Report; Amazon Gains On Solid Earnings [Feb-04-22 12:23PM] Stocks Drop as Jobs Report Increases Rate-Hike Jitters [Feb-04-22 12:05PM] Bristol-Myers (BMY) Q4 Earnings Meet Estimates, Sales Beat [Feb-04-22 11:45AM] Ruffer LLP Buys Kinross Gold Corp, Barrick Gold Corp, Hertz Global Holdings Inc, Sells Centene ... [Feb-04-22 01:38PM] Pictet North America Advisors SA Buys Fidelity National Information Services Inc, Johnson ... [Feb-04-22 01:38PM] Amazon, Snap Fuel Tech; Dow Drops on Rate Worries [Feb-04-22 02:19PM]
27-10-2021	PM	7:00 AM ET (Oct 27)	BMY	Bristol-Myers Squibb Company	127,990	2.00	1.91	1.63	Bristol Myers Squibb EPS beats by $0.08, beats on revenue, boost guidance [10/27/2021 7:02 AM]	56.49	-1.75 (-3.00%)	56.49	0.0 (0.00%)	56.11 - 69.75	18,450,664	9,380,000	91,210
Bristol Myers Squibb Q3 2021 Earnings Preview [10/26/2021 3:11 PM] Bristol Myers Squibb EPS beats by $0.08, beats on revenue, boost guidance [10/27/2021 7:02 AM] Bristol Myers Squibb posts Q3 earnings beat, FY forecast [10/27/2021 7:41 AM] Bristol-Myers hits a 52-week low despite Q3 beat [10/27/2021 10:59 AM] Hot Stocks: BMY sets low; SLAB hits new high; Solar stocks climb; CRTX plunges on clinical data; NRIX rises [10/27/2021 6:24 PM] SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS APPH, BMY, EAR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits [Oct-26-21 03:50PM] BRISTOL-MYERS CVR INVESTORS: December 6, 2021 Filing Deadline in Class Action Contact Lieff Cabraser [Oct-26-21 01:46PM] FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of APPH, BMY, EAR and HNST [Oct-26-21 10:37PM] Bristol Myers Squibb Reports Third Quarter Financial Results for 2021 [Oct-27-21 06:59AM] Bristol Myers reports 10% quarterly sales growth as cancer drugs rebound [Oct-27-21 06:59AM] Bristol Myers Squibb says sales of Revlimid, Eliquis increased in the third quarter [Oct-27-21 07:49AM] Bristol Myers Inches Up As Cancer Drugs Help Drive Narrow Quarterly Beat [Oct-27-21 09:02AM] Bristol Myers Squibb (BMY) Tops Q3 Earnings and Revenue Estimates [Oct-27-21 08:15AM] Earnings Data Deluge [Oct-27-21 09:53AM] Bristol-Myers (BMY) Beats on Q3 Earnings & Sales, Tweaks View [Oct-27-21 09:24AM] Bristol Myers Skids As Looming Generics Shadow Its Biggest Product [Oct-27-21 11:56AM] Biotech Stock Roundup: BMY's Q3 Earnings Beat, MRNA's Vaccine Updates & More [Oct-27-21 11:10AM] Q3 Earnings' Smooth Sailing Continues [Oct-27-21 10:27AM] Bristol Myers Q3 Earnings In-line With Expectations, Raises Lower End Of FY21 Adjusted EPS Outlook [Oct-27-21 09:21AM] SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Bristol-Myers Squibb Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm [Oct-27-21 07:13PM]
28-07-2021	PM	7:00 AM ET (Jul 28)	BMY	Bristol-Myers Squibb Company	151,140	1.93	1.88	1.63	Bristol Myers Squibb EPS beats by $0.03, beats on revenue [7/28/2021 7:00 AM]	68.73	1.24 (1.84%)	68.73	0.0 (0.00%)	56.75 - 68.99	10,394,788	8,430,000	14,383
Mizuho reiterates buy on BridgeBio following Bristol-Myers Squibb deal; sees 53% upside [7/27/2021 1:48 PM] Bristol Myers Squibb Q2 2021 Earnings Preview [7/27/2021 12:39 PM] Bristol Myers Squibb EPS beats by $0.03, beats on revenue [7/28/2021 7:00 AM] Bristol Myers posts Q2 earnings beat on Opdivo Strength [7/28/2021 7:54 AM] Top Analyst Reports for Comcast, Coca-Cola & Bristol-Myers Squibb [Jul-27-21 02:20PM] Drug/Biotech Stock Earnings on Jul 28: PFE, GSK, BMY, BMRN & TLRY [Jul-27-21 11:14AM] Infinity Pharma Stock Drops After Updated Data From Bladder & Breast Cancer Trials, Q2 Earnings [Jul-27-21 10:40AM] Why Its Hard to Go Wrong With Bristol Myers Stock [Jul-27-21 06:00AM] Bristol Myers sees return to growth for Opdivo, tops estimates [Jul-28-21 07:00AM] Bristol Myers Squibb Reports Second Quarter Financial Results for 2021 [Jul-28-21 06:59AM] Bristol Myers swings to profit to beat second-quarter estimates as Opdivo returns to growth [Jul-28-21 07:12AM] Bristol Myers Earnings Top Views; BMY Stock Just Below Buy Point [Jul-28-21 08:07AM] Bristol Myers Posts Stronger-Than-Expected Earnings but Lowers Guidance [Jul-28-21 04:47AM] Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Beat Estimates [Jul-28-21 08:15AM] Bristol Myers Squibb Stock Rises After Modest Earnings Beat [Jul-28-21 10:08AM] Bristol Myers Q2 Earnings Slightly Ahead Of Estimates, Trims FY21 GAAP EPS Guidance [Jul-28-21 07:42AM] Bristol Myers Retakes Buy Point After 'Solid' Quarter, Though Generics Loom [Jul-28-21 11:52AM] Bristol-Myers Squibb (BMY) Q2 2021 Earnings Call Transcript [Jul-28-21 12:00PM] Is BMY Stock A Buy After A Second-Quarter Beat As Revlimid Rivals Loom? [Jul-28-21 03:14PM] Bristol-Myers' (BMY) Q2 Earnings Beat, Opdivo Sales Grow [Jul-28-21 01:57PM]
29-04-2021	PM	7:00 AM ET (Apr 29)	BMY	Bristol-Myers Squibb Company	147,190	1.74	1.83	1.72	Bristol Myers Squibb EPS misses by $0.07, misses on revenue [4/29/2021 7:04 AM]	62.89	-3.14 (-4.76%)	62.89	0.0 (0.00%)	54.07 - 67.16	21,099,286	11,000,000	15,823
Bristol Myers Squibb Q1 2021 Earnings Preview [4/28/2021 12:34 PM] Bristol Myers Squibb EPS misses by $0.07, misses on revenue [4/29/2021 7:04 AM] Bristol Myers slips 3% as Q1 trails estimates; GAAP EPS guidance raised [4/29/2021 7:53 AM] Here is Why Growth Investors Should Buy Bristol Myers (BMY) Now [Apr-28-21 12:45PM] Pharma/Biotech Stocks' Q1 Earnings Queued for Apr 29: MRK, BMY & More [Apr-28-21 11:14AM] Bristol Myers Squibb to Take Part in the 7th Annual Truist Life Sciences Summit [Apr-28-21 06:59AM] 5 Surefire Dividend Stocks You Can Buy Right Now [Apr-28-21 06:06AM] Bristol Myers Squibb Co. to Host Earnings Call [Apr-29-21 06:45AM] Bristol Myers Squibb Reports First Quarter Financial Results for 2021 [Apr-29-21 06:59AM] Bristol Myers first-quarter earnings miss expectations as cancer drugs underperform [Apr-29-21 07:01AM] Bristol Myers Squibb stock falls, as profit and revenue rise but miss expectations [Apr-29-21 07:11AM] Bristol Myers Misses Earnings Forecast, Repeats 2021 Profit Guidance [Apr-29-21 03:08AM] Bristol Myers Stock Dives As First-Quarter Comes Up Unexpectedly Light [Apr-29-21 08:58AM] Bristol Myers Squibb (BMY) Q1 Earnings and Revenues Miss Estimates [Apr-29-21 08:25AM] Bristol Myers Squibb Stock Fell After Earnings. Heres Why. [Apr-29-21 09:04AM] Bristol Myers Stock Dives As First Quarter Comes Up Unexpectedly Light [Apr-29-21 08:58AM] Bristol-Myers (BMY) Misses on Q1 Earnings, Opdivo Sales Decline [Apr-29-21 09:29AM] What Went Wrong for Bristol Myers Squibb in Q1 [Apr-29-21 10:16AM] Bristol Myers Disappoints In First Quarter, But Retains Its Full-Year Guidance [Apr-29-21 10:59AM] Bristol-Myers Misses Q1 Profit As Pandemic Hits Cancer Drugs Sales [Apr-29-21 10:49AM] Why Bristol Myers Squibb Stock Fell Today [Apr-29-21 03:22PM]
04-02-2021	PM	7:00 AM ET (Feb 4)	BMY	Bristol-Myers Squibb Company	142,230	1.46	1.37	1.22	Bristol Myers Squibb EPS beats by $0.04, beats on revenue [2/4/2021 7:02 AM]	61.56	-0.29 (-0.76%)	61.74	-0.29 (-0.47%)	45.76 - 67.80	13,121,654	13,346,295	70,406
Bristol Myers Squibb EPS beats by $0.04, beats on revenue [2/4/2021 7:02 AM] Bristol Myers Squibb Q4 2020 Earnings Preview [2/3/2021 12:02 PM] Bristol Myers Squibb rises slightly on Q4 results; raises 2021 earnings guidance [2/4/2021 8:30 AM] Bristol Myers Squibb launches tender offers up to $4B [2/4/2021 8:25 AM] Is Bristol Myers Stock A Buy As Shares Flounder After Fourth-Quarter Beat? [Feb-04-21 01:40PM] Bristol-Myers (BMY) Q4 Earnings Beat, 2021 EPS View Raised [Feb-04-21 11:39AM] Bristol Myers Just Beat Estimates. The Stock Isnt Going Anywhere. [Feb-04-21 10:11AM] Bristol-Myers Flat After Report - Here's the Must-Hold Support Level [Feb-04-21 08:30AM] Bristol Myers Squibb Co. to Host Earnings Call [Feb-04-21 07:45AM] Bristol Myers posts $10 billion loss as it books charges relating to MyoKardia and Celgene [Feb-04-21 07:21AM] Bristol-Myers Squibb: Q4 Earnings Insights [Feb-04-21 07:18AM] Merck, Bristol Myers, PayPal - Thursday's Premarket Movers [Feb-04-21 03:33AM]
05-11-2020	PM	7:00 AM ET (Nov 5)	BMY	Bristol-Myers Squibb Company	138,030	1.63	1.49	1.17	Bristol Myers Squibb EPS beats by $0.14, beats on revenue [11/5/2020 7:01 AM]	63.75	-1.68 (-2.57%)	63.75	0.0 (0.00%)	45.76 - 68.34	13,304,474	11,304,800	534,460

06-08-2020	PM	7:00 AM ET (Aug 6)	BMY	Bristol-Myers Squibb Company	133,720	1.63	1.43	1.18	Bristol Myers Squibb EPS beats by $0.16, beats on revenue [8/6/2020 7:01 AM]	61.50	1.82 (3.04%)	62.20	2.51 (4.21%)	45.00 - 68.34	10,931,843	9,626,580	457,891